The peptide problem: Hype is outrunning the evidence The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT Why would a patient trust a peptide more than a statin? STAT Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype